Number of the records: 1
Lipophosphonoxins of second generation, and their use
- 1.
SYSNO ASEP 0552760 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title Lipophosphonoxins of second generation, and their use Author(s) Rejman, Dominik (UOCHB-X) RID, ORCID
Pohl, Radek (UOCHB-X) RID, ORCID
Zborníková, Eva (UOCHB-X) RID, ORCID
Krásný, Libor (MBU-M) RID, ORCID
Látal, T. (CZ)
Kolář, M. (CZ)Year of issue 2021 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. US11135237 Date of the patent acceptance 05.10.2021 Name of the patent owner Ústav organické chemie a biochemie AV ČR, v. v. i. - Mikrobiologický ústav AV ČR, v. v. i. - TRIOS, spol. s r. o Code of the issuer name US001 - United States Patent and Trademark Office (USPTO) Alexandria Current use A - Pouze udělený (dosud nevyužívaný) patent nebo patent využívaný jeho vlastníkem Language eng - English Keywords antibacterial ; lipophosphonoxin ; chemotherapeutic OECD category Medicinal chemistry R&D Projects TA02010035 GA TA ČR - Technology Agency of the Czech Republic (TA ČR) Institutional support UOCHB-X - RVO:61388963 ; MBU-M - RVO:61388971 Annotation Lipophosphonoxins of general Formula I are described, in which R1 is C8-C22, preferably C10-C18 and more preferably C12-C16 alkyl, or hexadecyloxypropyl, tetradecyloxypropyl, tetradecyloxyethyl or hexadecyloxyethyl, R2 is uracil, thymine, or cytosine, and R3 is selected from a group which contains compounds of general formulas II and III. Workplace Institute of Organic Chemistry and Biochemistry Contact asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418 Year of Publishing 2022 Electronic address https://worldwide.espacenet.com/patent/search/family/058668694/publication/US11135237B2?q=US11135237
Number of the records: 1